预约演示

Pantoprazole Cuts GI Bleeding in Patients Undergoing Invasive Ventilation

2024-06-17

临床结果

MONDAY, June 17, 2024 -- Pantoprazole results in a significantly lower risk for clinically important upper gastrointestinal bleeding than placebo, with no increase in mortality, among patients undergoing invasive ventilation, according to a study published online June 14 in the New England Journal of Medicine to coincide with the annual Critical Care Reviews Meeting, held from June 12 to 14 in Belfast, Northern Ireland.

Deborah Cook, M.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues assigned critically ill adults who were undergoing invasive ventilation to receive intravenous pantoprazole (40 mg daily) or matching placebo in an international randomized trial. Overall, 4,821 patients in 68 intensive care units were randomly assigned.

The researchers found that clinically important upper gastrointestinal bleeding occurred in 25 of 2,385 and 84 of 2,377 patients receiving pantoprazole and placebo, respectively (1.0 versus 3.5 percent; hazard ratio, 0.30; 95 percent confidence interval, 0.19 to 0.47; P

"The use of pantoprazole resulted in a lower risk of clinically important upper gastrointestinal bleeding than the use of placebo, with no overall effect on mortality," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

More Information

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构